Calithera Biosciences, Inc.
Compositions and methods for inhibiting arginase activity
Last updated:
Abstract:
The invention relates to methods of treating cancer, with a combination of an arginase inhibitor and a chemotherapeutic agent. The invention further relates to methods of assessing efficacy of a cancer treatment by measuring arginine levels in a tumor.
Status:
Grant
Type:
Utility
Filling date:
29 Jul 2019
Issue date:
2 Feb 2021